radiopharmaceuticals

Alzheimers brain
MedTech

FDA clears Lantheus’ Alzheimer’s PET imaging agent Tauklarify

Lantheus, which recently agreed to a takeover by fellow radiopharma Curium, garnered FDA clearance for its Alzheimer’s PET imaging agent Tauklarify.
Joseph Keenan Aug 17, 2026 7:51am
Graphic image of a red thumbs down against a blue background
Favicon Fierce Pharma

ITM cancer drug spurned by FDA over manufacturing qualms

Aug 10, 2026 11:25am
MA

Curium strikes up to $8B deal for radiopharma rival Lantheus

Aug 3, 2026 2:20pm
Novartis booth at AACR 2026

Novartis drops ph. 2-stage radioligand therapy over poor data

Jul 21, 2026 8:18am
FDA

Production problems hamper Lantheus FDA approval of dx kit

Jun 29, 2026 8:31am
Telix booth at ASCO 2026

ASCO: Telix tees up pivotal test for Pluvicto challenger

Jun 1, 2026 4:12pm